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Background: Pills (tablets and capsules) are widely used to administer prescription drugs or to take
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to swallow these various pills. More speciﬁcally, it is not known to what extent hard-to-swallow pills
might affect treatment outcomes (eg, interfering with adherence to prescribed medications or causing
clinical complications). It is also unclear which properties (eg, size, shape, or surface texture) Americans
prefer or reject for their pills. To learn more about these issues, we interviewed a small group of
individuals.
Methods: We invited individuals in waiting rooms of our tertiary health care center to participate in
structured interviews about their pill-taking habits and any problems they have swallowing pills. We
inquired which pill properties they believed caused swallowing problems. Participants scored capsules
and pills of representative size, shape, and texture for swallowing effort and reported their personal
preferences.
Results: Of 100 successive individuals, 99 participants completed the interview (65% women, mean age
¼ 41 years, range ¼ 23-77 years). Eighty-three percent took pills daily (mean 4 pills/d; 56% of those pills
were prescribed by providers). Fifty-four percent of participants replied yes to the question, "Did you
ever have to swallow a solid medication that was too difﬁcult?" Four percent recounted serious
complications: 1% pill esophagitis, 1% pill impaction, and 2% stopped treatments (antibiotic and prenatal
supplement) because they could not swallow the prescribed pills. Half of all participants routinely
resorted to special techniques (eg, plenty of liquids or repeated or forceful swallows). Sixty-one percent
of those having difﬁculties cited speciﬁc pill properties: 27% blamed size (20% of problems were caused
by pills that were too large whereas 7% complained about pills that were too small to sense); 12% faulted
rough surface texture; others cited sharp edges, odd shapes, or bad taste/smell. Extra-large pills were
widely loathed, with 4 out of 5 participants preferring to take 3 or more medium-sized pills instead of a
single jumbo pill.
Conclusions: Our survey results suggest that 4 out of 5 adult Americans take several pills daily, and do so
without undue effort. It also suggests that half of today’s Americans encounter pills that are hard to
swallow. Up to 4% of our participants gave up on treatments because they could not swallow the
prescribed pills. Up to 7% categorically rejected taking pills that are hard to swallow. Speciﬁc material
properties are widely blamed for making pills hard to swallow; extra-large capsules and tablets are
universally feared, whereas medium-sized pills with a smooth coating are widely preferred. Our ﬁndings
suggest that health care providers could minimize treatment failures and complications by prescribing
and dispensing pills that are easy to swallow. Industry and regulatory bodies may facilitate this by
making swallowability an essential criterion in the design and licensing of oral medications. Such policies
could lessen the burden of pill taking for Americans and improve the adherence with prescribed
treatments.
Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).pen access article under the CC BY
Disease Week 2013, May 20,
University of Iowa Hospitals
Hawkins Dr, 4551 JCP, Iowa
chulze).Introduction
In a population survey conducted more than 30 years ago1 40%
of American adults reported pills getting stuck in their throat; that-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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(globus). Similar ﬁndings were reported in Norway,2,3 and recently
in Germany.4 In our gastroenterology practice, we regularly ask
patients about problems swallowing food. Many patients take that
occasion to complain about having a hard time swallowing some
pills. This made us wonder to what extent today’s Americans
experience difﬁculties when taking pills and how this relates to
speciﬁc pill properties. We asked 100 individuals in waiting areas
of our tertiary health care center whether they experienced
problems when swallowing pills and which properties make pills
hard to swallow.Methods
Following approval by the Institutional Review Board we
conducted structured interviews in waiting areas of University of
Iowa Hospitals and Clinics. We approached the drivers (eg,
relatives and friends) of patients undergoing endoscopic proce-
dures and individuals having prescriptions ﬁlled at the outpatient
pharmacy (we assume they were mostly patients who attended a
specialty clinic that day). Once consent was obtained, we con-
ducted structured interviews with participants. Our questionnaires
were previously designed and tested with input from physicians,
nurses, secretaries, and ancillary personnel of the tertiary health
center. The ﬁrst questionnaire focused on the participant’s age and
history of pill taking, including number of daily pills, prescribed by
a provider or self, problems swallowing pills/food, and techniques
used to deal with difﬁcult pills (see Supplemental Figure 1 for a
complete list of questions). Using actual samples of common
medications as models (Figure), the second interview
(Supplemental Figure 2) inquired about preferences for pill size,
shape, and texture. Many questions addressed similar issues from
different angles and viewpoints to serve as internal controls.Figure. Examples of pills with different properties. In conjunction with Question-
naire 2 (Supplemental Figure 2), participants were shown and asked to feel
commonly used pills. They were asked to place pills into score boxes labeled
according to swallowing effort (1 ¼ easy, 2 ¼ slight, 3 ¼ considerable, and 4 ¼
hard/impossible). Participants were also asked to compare pills of different type
(capsule vs tablet), size (large, medium, or small), shape (round or oblong), and
coating/textures (ﬁrm, smooth, or crumbling) and indicate their preference of one
over the other.Participants provided estimates of their swallowing effort by
placing the pill samples into score boxes (box 1 ¼ easy, no effort
and box 4 ¼ hard or impossible to swallow).
All interviews were conducted during summer 2012 by fellows
in gastroenterology-hepatology. Before this, fellows went through
the structured interview with 1 of the authors. They then per-
formed mock interviews with peers while being supervised by 1 of
the authors. Fellows did not obtain a medical history from
participants or inquire what their medications were for. Fellows
were debriefed after completing the interviews.Results
Population
Of a total of 100 individuals who consented all but 1 completed
the structured interviews (73 were drivers—family or friends—of
patients undergoing endoscopic procedures and 26 were individ-
uals waiting to have a prescription ﬁlled). Table I gives demo-
graphic characteristics of the participants and their pill-taking
habits. The majority took several pills daily, spending only a few
seconds on individual pills and no more than 1 minute on all pills.
Those following a regimen of 10 or more pills estimated that it
took them about 1 minute per pill. Most participants swallowed
every pill separately; a few hurried and swallowed handfuls of
pills all at once.
Problems swallowing pills
Half of participants reported having problems swallowing some
of their pills (Table I), with 10% strongly expressing that those pills
“should never have been made or used.” Seven percentTable I
Interview participant characteristics and experiences with pills.*
Variable Result
Approached 100
Completed structured interviews 99
Age (y) 41
Range (y) 23–77
Female gender (%) 66
Taking pills on a daily basis (%) 81
No. of daily pills 4.1
Range 1–19
Taking 5 or more (%) 27
Taking 10 or more (%) 10
Taking 15 or more (%) 5
Prescribed by provider vs self (%) 56 vs 44
Sometimes experienced difﬁculties with pills (%) 54
Frequent ongoing pill sticking/globus sensation (%) 13
Solid food dysphagia (%) 8
Pills as bad as food (%) 5
Pills worse than food (%) 2
Clinical complications from pill swallowing† (%) 4
Measures to ensure effective swallowing (%)
Plenty of water 55
Series of power swallows 33
Cut, break, or crush large tablets 30
Swallow in viscous medium (eg, apple sauce or chewed bread) 7
Stop hard-to-swallow medication 6
Position pill to back of tongue, turning head 2
Open capsule, swallow contents 1
Request easier preparation 1
n Participants were visitors approached in clinic waiting rooms. Sixty-six were
family or friends of patients undergoing an endoscopic procedure. Thirty-four were
passing through the outpatient pharmacy.
† Clinical complications included 1 report of pill esophagitis, 1 report of pill
impaction leading to persistent fright of all oral medications, and 3 reports of
stopped prescribed medications.
Table II
Pill properties, problems, and preferences revealed during structured interviews
Interview interest area Result
Cause of difﬁculty (%)
Pills too large or bulky 20
Difﬁculties with speciﬁc large capsules* 6
Difﬁculties with speciﬁc large tablets† 6
Small pills or pill fragments‡ 7
Pills too dry, rough, sticky or hard 12
Pill of odd shape, with sharp edges 3
Pills smell/taste bad 3
Preferences regarding pill properties (%)
Capsules vs tablets 50 vs 49
Round vs oblong (oval) 50 vs 49
Coated vs chewable 90 vs 9
Anticipated swallowing effort§
Jumbo tablets or capsules (413  4  4 mm)† 3.6
Small coated tablet (low-dose aspirin) 1.2
Medium-sized tablets with smooth coating 1.3-1.6
n Antibiotic agents were a common active ingredient of very large capsules.
† Calcium and potassium were common ingredients of jumbo tablets.
‡ Small pills or pill fragments included preparations of thiazide diuretics,
thyroid supplement, birth control pills, beta-blocking agents, and histamine
2 blockers.
§ 1 ¼ easy to swallow to 4 ¼ hard/impossible to swallow
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percent recounted serious complications: 1% pill esophagitis, 1%
pill impaction, and 2% stopped treatments (an antibiotic and a
prenatal supplement) because they could not swallow the
prescribed pills.
Responsible pill properties
Many participants (37%) faulted speciﬁc pill properties (Figure)
for problems taking pills (Table II), with size the most common
complaint. Jumbo tablets and capsules were widely loathed, and
4 out of 5 participants would rather take the requisite amount of
drug in several medium-sized preparations. Tiny tablets and split
pills were disliked for being hard to sense, gritty, and prone to
stick to gums. Six female participants voiced frustrations with
tablets sized 4 mm or less, whereas 2 tall men objected even to
tablets 4 to 5 mm in size. All participants expressed that medium-
sized pills with smooth coatings were easy to swallow and gave
oval caplets of 6 mm length a near perfect swallow score, and
gave extra-large tablets with a rough surface a failing score.
Participants split evenly regarding type and shape of pills they
preferred: half preferred capsules to tablets of the same size,
praising their smoothness and easy gliding. The other half rejected
capsules for being sticky and dissolving too easily. Given their
choice of shape, half of the participants opted for oval, and the
other half opted for round tablets of the same size. Only 9% opted
for the chewable preparation of low-dose aspirin. All others
preferred the coated variety of low-dose aspirin.Discussion
Pills (ie, tablets and capsules) are widely used for the oral
delivery of drugs (therapeutic agents and supplements of vitamins
or minerals) but little is known about efforts or problems Amer-
icans might have taking these pills. Pills are speciﬁcally prepared
as stable vehicles for drugs that upon swallowing release precise
amounts of active ingredients in the intestine.4 Their design and
manufacture is not speciﬁcally geared at making pills easy to
swallow. No industrial guidelines exist that ensure the swallow-
ability of pills, and regulatory bodies do not ensure that pills
require no undue swallowing effort. Little is known about materialproperties that might affect the oropharyngeal transit and swal-
lowability of pills. Pill dysphagia is not reported as a side effect of
taking drugs.4,5
Our survey results suggest that 4 out of 5 Americans take pills
on a daily basis and that about half have encountered pills that are
hard to swallow. Half of our participants regularly make extra
efforts when swallowing difﬁcult pills and 4 out of 5 preferred to
take several medium-sized pills over 1 jumbo pill. Four partic-
ipants experienced serious complications, including pill esophagitis,
pill impaction, or failure to complete treatments because of pills that
were hard to swallow.
One may question how representative our ﬁndings are for the
American public at large. The scope of our study is limited by the
small number of participants, and by selecting participants among
visitors to our tertiary health care center. Individuals who accom-
pany patients to endoscopic procedures and especially individuals
waiting to have medications ﬁlled might very well take more pills
and experience more problems swallowing than a typical Amer-
ican. On the other hand we did not speciﬁcally select populations
likely to experience pill dysphagia such as the very young or very
old, patients taking many medications or with multiple comorbid-
ities, or patients with cerebrovascular disease.6–8 We have virtually
no information on the health status of our participants and for that
reason alone we cannot claim that our ﬁndings are representative
of the American public at large or speciﬁc population groups. The
shortcomings of our study should not distract from 2 important
ﬁndings: far too many Americans experience problems swallowing
some pills and most of these problems might be prevented by the
use of easy-to-swallow pills. Both of these ﬁndings are in line with
the results of large American and Norwegian surveys performed
years ago and a German survey conducted around the same time
as ours.1–5,9–11 Like the recent German work,4 our study revealed
serious problems and complications caused by hard-to-swallow
pills that should not be ignored, even if they occur much less
commonly than reported here. Similar to the German study,4 our
participants admitted to opening, breaking, or crushing pills
without checking with a health care provider. Such tampering
could be harmful by interfering with the pharmacodynamic
parameters and safety proﬁles of preparations that are speciﬁcally
formulated for controlled release of active ingredients.4
Physical properties of pills remain a common source of frus-
tration. Jumbo pills are known to require multiple swallows to
clear the esophagus and are prone to causing pill dysphagia.4,12 At
least one-third of participants blamed wrong size, shape, or
texture for making pills difﬁcult to swallow. Extra-large, bulky
capsules and tablets were loathed by virtually every participant.
Most participants expressed a preference for taking several
medium-sized pills over a single bulky pill. It is noteworthy that
many participants loathed pills that are too small. Small pills are
difﬁcult to sense, leading to uncertainty about their clearance from
the oropharynx. This also might explain the aversion of many
participants to chewable tablets: little fragments can stick to gums
or in mouth recesses. These ﬁndings suggest it would be ideal if all
oral medicinal preparations were of medium size, meaning a pill
length of between 6 and 13 mm. This range is similar to the
dimensions of capsules and tablets that caused least difﬁculties in
a German family practice population.4 Further studies may help to
determine the optimal upper and lower limits of pill size for a
typical American. Eventually, it might help to know how gender,
age, body size, and speciﬁc medical conditions affect a patient’s
ability to swallow pills.
The width and height of pills, their shape, and their surface
texture are additional parameters that affect swallowing. Capsules
18 mm in length were readily acceptable to German patients who
had problems with round tablets 48 mm diameter, and oblong or
oval tablets 413 mm.4 Our participants wished for a ﬁrm and
J. Fields et al. / Current Therapeutic Research 77 (2015) 79–8282smooth coating for pills to glide easily without sticking or
disintegrating, but disagreed whether capsules or tablets better
ﬁt that bill. They were evenly divided regarding the ideal shape of
tablets, with as many preferring round, ﬂat tablets as oblong or
oval ones. Oblong tablets clear the esophagus quicker than round
ones,12 but how pill shape affects the oropharyngeal passage and
clearance has not been studied in detail. Pills presumably follow
the same general trajectory as food and drink from the dorsum of
the tongue through the left or right piriform sinus and into the
esophageal inlet. Yet pills are profoundly different from a malle-
able bolus of food that readily adapts its shape to the structures
through which it passes. Pills may collide with and be deﬂected by
pharyngeal structures, and therefore be in need of repeated course
corrections. It is conceivable that short, oval or round pills readily
bounce off or roll over obstacles, whereas long or oblong pills
would be likely to get stuck. This might explain the preference for
round, oval, or even odd pill shapes that many of our participants
and German patients4 expressed.
It would be good to take measures to reduce the burden of pill
taking for Americans at large, and presumably even more so for
patients with swallowing problems (whether from cerebrovascu-
lar accidents, oropharyngeal operations, or other disease proc-
esses). Rapidly disintegrating compounds have been developed for
this explicit purpose, and have been shown to outperform solid
pills in patients with dysphagia.5 Carnaby-Mann et al5 pioneered
the objective assessment of pill swallowing by measuring patient
acceptance, swallow effort, and effectiveness of oropharyngeal
clearance. Similar studies might help to design and market addi-
tional preparations that require minimal swallowing effort. Imag-
ing studies might provide a better understanding of the dynamic
interactions of pills with oropharyngeal structures.13–17 Ultimately,
it might be possible to design a drug-delivery vehicle that outper-
forms currently available capsules and tablets for the swift and
effortless oral delivery of medications. Regulatory bodies like the
Food and Drug Administration should be called upon to provide
guidelines for the manufacture and prescription of pills that are
easy to swallow. It might also help if regulatory bodies reported on
hard-to-swallow preparations and advised on which preparations
can safely be cut down in size or taken apart. Health care
providers, including pharmacists, ideally should regularly ask
patients about their preferences, and preferentially prescribe and
dispense medicinal formulations requiring minimal swallowing
effort. Health care providers often choose to prescribe large pills in
an effort to keep the total number of pills in a regimen to a
minimum. Unfortunately this strategy seems to more often
increase rather than decrease the pill burden to patients and
contribute to decreased satisfaction because patients believe their
health care providers are ignoring preferences or underrating
swallowing problems, especially when it comes to unwieldy pills.Acknowledgments
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